National Healthcare (NHC) EPS (Weighted Average and Diluted) (2010 - 2026)

National Healthcare has reported EPS (Weighted Average and Diluted) for 17 years, with the latest figure at $2.27 in Q1 2026.

• For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) rose 9.66% year-over-year to $2.27; the trailing twelve-month figure through Mar 2026 stood at $7.86 (up 13.75% YoY), and the FY2025 full-year result was $7.67, up 17.46% from the prior year.
• EPS (Weighted Average and Diluted) for Q1 2026 stood at $2.27, up from $1.57 in the prior quarter.
• The five-year high for EPS (Weighted Average and Diluted) was $2.73 in Q3 2024, with the low at -$0.16 in Q3 2022.
• Historically, EPS (Weighted Average and Diluted) has averaged $1.31 across 5 years, with a median of $1.52 in 2025.
• Annual changes were most pronounced in 2022 — EPS (Weighted Average and Diluted) slumped 96.91% — and 2023, when it jumped 525.0%.
• National Healthcare's EPS (Weighted Average and Diluted) stood at $0.41 in 2022, then soared by 348.78% to $1.84 in 2023, then slumped by 79.35% to $0.38 in 2024, then soared by 313.16% to $1.57 in 2025, then surged by 44.59% to $2.27 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at $2.27 (Q1 2026), $1.57 (Q4 2025), and $2.5 (Q3 2025), per Business Quant data.